Ticker brief
GH GUARDANT HEALTH INC
Consumer, Non-cyclical · Healthcare-Products
last close
$169.08
1 day
+3.8%
14 days
+1.0%
mkt cap
$22.3B
signals 14d
29
authors 14d
21
crowd 14d
-1.2σ
Options inteloptions-surface reads · latest available day per source
| metric | reading | context |
|---|---|---|
| IV — ATM 30d | 73% rich · 92 pctile own 1y | IV/HV 1.44× |
| Skew — 25Δ RR 30d | +0.075 100 pctile own 1y | calls bid vs puts (call skew rich) |
| Net dealer OI (NDOI) | +0.64 elevated | 5-session Δ +0.08 (as of 2026-07-06) |
| OI alarm | quiet | last alarm 2026-04-30 (z=2.6) |
| Next earnings | 2026-11-05 (proj) | in 10d |
| CSP screen | rank #65 · $155.3 strike · 1.18% prem | on the CSP screen (2026-10-23) |
Sentiment — last 14 days
daily mean sentiment, 2026-10-03 → 2026-10-15 · now -0.30 (−1 bearish … +1 bullish)
Who spoke21
| author | grade | trader score | signals | mean sent |
|---|---|---|---|---|
| @BrocksStocks1 | C | +0.63 | 4 | +0.23 |
| @TomLambos | C | -2.87 | 2 | +0.03 |
| @TedHZhang | B | -2.90 | 2 | +0.03 |
| @TheNewMoney_app | C | · | 2 | +0.33 |
| @NickDrendel | C | -2.37 | 2 | -0.28 |
| @cnfinancewatch | B | -1.23 | 2 | +0.40 |
| @nanalyzetweets | B | +5.59 | 1 | +0.20 |
| @DarvasBoxAI | C | -0.73 | 1 | +0.65 |
| @kkernttb | C | -0.95 | 1 | +0.35 |
| @PrimeTrading_ | C | -2.18 | 1 | +0.20 |
| @Sebagyeong | C | -1.16 | 1 | +0.00 |
| @LeifSoreide | C | -0.79 | 1 | +0.80 |
| @cfromhertz | B | -0.96 | 1 | +0.35 |
| @IBDinvestors | B | +0.09 | 1 | +0.20 |
| @AlexMarenco1 | C | -1.18 | 1 | +0.20 |
| @FranVezz | C | -1.47 | 1 | +0.40 |
| @PurpleDrink_LLC | C | -0.89 | 1 | -0.55 |
| @ye4yn | B | -0.66 | 1 | +0.60 |
| @ConnorJBates_ | B | -0.78 | 1 | -0.20 |
| @KeithTradeSmith | C | +1.08 | 1 | +0.65 |
| @CHItrader | B | -0.22 | 1 | -0.20 |
Recent signals29of 29 in 14d — receipts included
| date (PT) | author | sent | what they said | since then | receipt |
|---|---|---|---|---|---|
| 2026-10-15 | @NickDrendel | -0.40 | Daily watchlist identifies long and short setups without concrete entry intent. | +1.9% | tweet ↗ |
| 2026-10-15 | @CHItrader | -0.20 | The Patent Trial and Appeal Board rejected Guardant Health's challenge to a core TwinStrand patent. | +1.9% | tweet ↗ |
| 2026-10-13 | @cnfinancewatch | +0.40 | The table reports multiple analyst price-target increases across six directly listed stocks. | +4.3% | tweet ↗ |
| 2026-10-12 | @TheNewMoney_app | +0.30 | Reports a large purchase of GH Jan 2027 $230 calls. | +3.9% | tweet ↗ |
| 2026-10-12 | @cnfinancewatch | +0.40 | Lists six recent sell-side price-target increases with prior and new targets. | +3.9% | tweet ↗ |
| 2026-10-08 | @KeithTradeSmith | +0.65 | AI-driven genomics is presented as an early-stage secular theme with further upside after pullbacks. | +2.1% | tweet ↗ |
| 2026-10-06 | @BrocksStocks1 | +0.30 | Discloses having been a GH buyer. | -0.9% | tweet ↗ |
| 2026-10-06 | @BrocksStocks1 | -0.50 | Recaps portfolio reduction, wins, a stop-out, and trims across five stocks. | -0.9% | tweet ↗ |
| 2026-10-06 | @ConnorJBates_ | -0.20 | The author describes rotation from extended genomics leaders into laggards and warns against late breakouts. | -0.9% | tweet ↗ |
| 2026-10-06 | @ye4yn | +0.60 | Adding to HNGE, GH and HTFL after the medical-tech selloff. — Explicitly says the top-ranked medical-tech holdings were increased after broad weakness. | -0.9% | tweet ↗ |
| 2026-10-06 | @TomLambos | -0.50 | Reports being stopped out of GH and exiting SKHY after a reversal. | -0.9% | tweet ↗ |
| 2026-10-06 | @PurpleDrink_LLC | -0.55 | Sarcastically criticizes GH's breakout setup and says most such breakouts failed this year. | -0.9% | tweet ↗ |
| 2026-10-06 | @FranVezz | +0.40 | Expresses amazement at the named genomics stocks' price action. | -0.9% | tweet ↗ |
| 2026-10-06 | @NickDrendel | -0.15 | Calls the genomics move a character change and expects a basing process. | -0.9% | tweet ↗ |
| 2026-10-06 | @TedHZhang | -0.35 | Attributes violent biotech moves to positioning unwinds; ticker count capped at six. | -0.9% | tweet ↗ |
| 2026-10-05 | @AlexMarenco1 | +0.20 | Reports new index highs, distribution-day counts and 80%-100% exposure. | -9.7% | tweet ↗ |
| 2026-10-05 | @TheNewMoney_app | +0.35 | Reports a large purchase of GH 260 calls expiring in 2027. | -9.7% | tweet ↗ |
| 2026-10-05 | @IBDinvestors | +0.20 | Reports a Nasdaq breakout to new highs with Shopify, Taiwan Semi, and Guardant in focus. | -9.7% | tweet ↗ |
| 2026-10-05 | @cfromhertz | +0.35 | Presents a core-and-satellite approach for trading the genomics theme after ARKG gained 4%. | -9.7% | tweet ↗ |
| 2026-10-05 | @LeifSoreide | +0.80 | Added GH today, seeking a year-end move from its tight, powerful base. — Author explicitly added GH and presents its tight base as a preferred setup for year-end gains. | -9.7% | tweet ↗ |
| 2026-10-05 | @BrocksStocks1 | +0.35 | Suggests GH is beginning an upside move. | -9.7% | tweet ↗ |
| 2026-10-05 | @TedHZhang | +0.40 | Focus-list watchlist identifies constructive setups and explicit theses without concrete entry intent. | -9.7% | tweet ↗ |
| 2026-10-04 | @Sebagyeong | +0.00 | Detailed BLLN thesis finds strong growth and profitability but questions valuation, moat and 20x upside. | -4.9% | tweet ↗ |
| 2026-10-04 | @PrimeTrading_ | +0.20 | Ranks liquid leaders showing ten-week moving-average pullback structures; capped at six. | -4.9% | tweet ↗ |
| 2026-10-04 | @TomLambos | +0.55 | Highlights GH at a five-year cup pivot with strong relative-strength metrics. | -4.9% | tweet ↗ |
| 2026-10-04 | @kkernttb | +0.35 | Lists the first six IBD 50 names as preferred technical setups. | -4.9% | tweet ↗ |
| 2026-10-04 | @DarvasBoxAI | +0.65 | Explicitly states a continuing long position in GH. | -4.9% | tweet ↗ |
| 2026-10-03 | @nanalyzetweets | +0.20 | Presents genomics stocks to consider across genetic testing and gene-editing categories. | -4.9% | tweet ↗ |
| 2026-10-03 | @BrocksStocks1 | +0.75 | Adding GH on a breakout Monday. — States a concrete forward plan to add GH if it breaks out Monday. | -4.9% | tweet ↗ |
“Since then” = price move from the close on the signal's date (PT) to the latest close — what happened after they said it, not a backtest. A — means no trading session has closed since the signal yet. Sentiment is our extracted per-tweet score, −1…+1.